Top of page Skip navigation

 Genesis Sessions 2019

Programme

08.00 Registration

09.00: Welcome from One Nucleus

09.15: Winners and Losers 2019

Mike Ward, Pharma Intelligence & Datamonitor

09.40: Keynote Presentations

Speakers tbc

10.40: BioNewRound Award presentations


11.00: Coffee Break

11.30: Parallel Leadership Sessions 1

Understanding Market Makers - Anti-Infectives
Peter Jackson, AMR Centre

Nurturing Digital Health Champions Improving patient adherence with digital health
Cambridge Wireless

Redefining Therapeutics AreasIs prevention the new cure?
Shumone Sumantra, NNEdPro

Meeting Biotech Rising Stars
Oliver Sexton, Midven


12.30: Lunch

Including a panel discussion supported by Alderley Park

14.00: Parallel Leadership Sessions 2

Understanding Market Makers - Metabolic Disorders

Nurturing Digital Health Champions Understanding industry and NHS needs for digital health

Redefining Therapeutics Areas New technology paradigms
Davidson Ateh, BioMoti

Meeting Biotech Rising Stars


15.00: Coffee Break

15.30: Parallel Leadership Sessions 3

Understanding Market Makers - Immuno-oncology

Nurturing Digital Health Champions Digital Health delivery – an international example  
Swelife

Redefining Therapeutics AreasFrom rare disease to unique approach
Genomics England

Meeting Biotech Rising Stars
Michael Anstey, Cambridge Innovation Capital
Jason Mellad, StartCodon


16.35 – 17.35 Plenary Debate – Are Targets the best way to drive Performance? 

Often performance and targets come hand in hand. But this is questioning our definition of targets and tangible outcomes and how we measure performance. This session will review good and bad examples of performance drivers and will discuss whether evrything is measurable.   

17.35 – 17.40 Closing Remarks 

17.40 – 19.00 Drinks Reception

 

4 Parallel Leadership Sessions

Understanding Market Makers

If cash is king, understanding investment drivers is key. This stream will discuss three different therapeutic areas from a perspective of what is driving their attraction to investors and Pharma.  

Nurturing Digital Health Champions

This stream will highlight the key success factors in digital health with examples of success stories and enablers.

Redefining Therapeutics Areas

This stream will review areas of expertise and technologies that are contributing to redefine the scope of therapeutics areas.

Is prevention the new cure? With insights from healthcare and nutritional sciences and their contribution to therapeutic understanding and efficacy

- New technology paradigms. Covering areas like bioelectronics, nanotechnologies or synthetic biology and their contribution to new therapeutics development

From rare disease to unique approach – with genomics being a game changer in rare diseases research, what lessons can be translated into other areas       

 

Meeting Biotech Rising Stars

This stream will provide a snapshot of the future biotech landscape with presentations from leading investors and their portfolio companies  


Sponsors